443 related articles for article (PubMed ID: 38002335)
41. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease.
Rosillo MA; Sanchez-Hidalgo M; Cárdeno A; de la Lastra CA
Biochem Pharmacol; 2011 Oct; 82(7):737-45. PubMed ID: 21763290
[TBL] [Abstract][Full Text] [Related]
42. Role of ellagic acid in regulation of apoptosis by modulating novel and atypical PKC in lymphoma bearing mice.
Mishra S; Vinayak M
BMC Complement Altern Med; 2015 Aug; 15():281. PubMed ID: 26276710
[TBL] [Abstract][Full Text] [Related]
43. Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells.
Hagiwara Y; Kasukabe T; Kaneko Y; Niitsu N; Okabe-Kado J
Int J Hematol; 2010 Jul; 92(1):136-43. PubMed ID: 20559758
[TBL] [Abstract][Full Text] [Related]
44. Ellagic acid and human cancers: a systems pharmacology and docking study to identify principal hub genes and main mechanisms of action.
Cheshomi H; Bahrami AR; Matin MM
Mol Divers; 2021 Feb; 25(1):333-349. PubMed ID: 32410114
[TBL] [Abstract][Full Text] [Related]
45. Ellagic acid attenuates bleomycin and cyclophosphamide-induced pulmonary toxicity in Wistar rats.
Saba ; Khan S; Parvez S; Chaudhari B; Ahmad F; Anjum S; Raisuddin S
Food Chem Toxicol; 2013 Aug; 58():210-9. PubMed ID: 23603381
[TBL] [Abstract][Full Text] [Related]
46. The anti-oncogenic influence of ellagic acid on colon cancer cells in leptin-enriched microenvironment.
Yousef AI; El-Masry OS; Yassin EH
Tumour Biol; 2016 Oct; 37(10):13345-13353. PubMed ID: 27460082
[TBL] [Abstract][Full Text] [Related]
47. Combination effects of ellagic acid with erlotinib in a Ba/F3 cell line expressing EGFR H773_V774 insH mutation.
Xie C; Kong J; Miao F; Wang X; Sheng J
Thorac Cancer; 2020 Aug; 11(8):2101-2111. PubMed ID: 32525282
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.
Munagala R; Aqil F; Vadhanam MV; Gupta RC
Cancer Lett; 2013 Oct; 339(2):175-84. PubMed ID: 23791885
[TBL] [Abstract][Full Text] [Related]
49. Ellagic Acid Reduces High Glucose-Induced Vascular Oxidative Stress Through ERK1/2/NOX4 Signaling Pathway.
Rozentsvit A; Vinokur K; Samuel S; Li Y; Gerdes AM; Carrillo-Sepulveda MA
Cell Physiol Biochem; 2017; 44(3):1174-1187. PubMed ID: 29179217
[TBL] [Abstract][Full Text] [Related]
50. Ellagic acid inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and prevents atheroma formation in streptozotocin-induced diabetic rats.
Rani UP; Kesavan R; Ganugula R; Avaneesh T; Kumar UP; Reddy GB; Dixit M
J Nutr Biochem; 2013 Nov; 24(11):1830-9. PubMed ID: 23866995
[TBL] [Abstract][Full Text] [Related]
51. Ellagic acid protects dopamine neurons from rotenone-induced neurotoxicity via activation of Nrf2 signalling.
Wei YZ; Zhu GF; Zheng CQ; Li JJ; Sheng S; Li DD; Wang GQ; Zhang F
J Cell Mol Med; 2020 Aug; 24(16):9446-9456. PubMed ID: 32657027
[TBL] [Abstract][Full Text] [Related]
52. Research progress on the anticarcinogenic actions and mechanisms of ellagic acid.
Zhang HM; Zhao L; Li H; Xu H; Chen WW; Tao L
Cancer Biol Med; 2014 Jun; 11(2):92-100. PubMed ID: 25009751
[TBL] [Abstract][Full Text] [Related]
53. The anti-tumourigenic effect of ellagic acid in SKOV-3 ovarian cancer cells entails activation of autophagy mediated by inhibiting Akt and activating AMPK.
Elsaid FG; Alshehri MA; Shati AA; Al-Kahtani MA; Alsheri AS; Massoud EE; El-Kott AF; El-Mekkawy HI; Al-Ramlawy AM; Abdraboh ME
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1611-1621. PubMed ID: 32415699
[TBL] [Abstract][Full Text] [Related]
54. Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling.
Sharma M; Li L; Celver J; Killian C; Kovoor A; Seeram NP
J Agric Food Chem; 2010 Apr; 58(7):3965-9. PubMed ID: 20014760
[TBL] [Abstract][Full Text] [Related]
55. Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway.
Umesalma S; Sudhandiran G
Eur J Pharmacol; 2011 Jun; 660(2-3):249-58. PubMed ID: 21463623
[TBL] [Abstract][Full Text] [Related]
56. The polyphenol ellagic acid exerts anti-inflammatory actions via disruption of store-operated calcium entry (SOCE) pathway activators and coupling mediators.
Murphy MT; Qin X; Kaul S; Barrientos G; Zou Z; Mathias CB; Thomas D; Bose DD
Eur J Pharmacol; 2020 May; 875():173036. PubMed ID: 32101765
[TBL] [Abstract][Full Text] [Related]
57. Ellagic acid confers protection against gentamicin-induced oxidative damage, mitochondrial dysfunction and apoptosis-related nephrotoxicity.
Sepand MR; Ghahremani MH; Razavi-Azarkhiavi K; Aghsami M; Rajabi J; Keshavarz-Bahaghighat H; Soodi M
J Pharm Pharmacol; 2016 Sep; 68(9):1222-32. PubMed ID: 27364420
[TBL] [Abstract][Full Text] [Related]
58. Ellagic acid attenuates testicular disruption in rheumatoid arthritis via targeting inflammatory signals, oxidative perturbations and apoptosis.
Arab HH; Gad AM; Fikry EM; Eid AH
Life Sci; 2019 Dec; 239():117012. PubMed ID: 31678279
[TBL] [Abstract][Full Text] [Related]
59. Antiinflammatory and anti-cancer activities of pomegranate and its constituent, ellagic acid: Evidence from cellular, animal, and clinical studies.
Baradaran Rahimi V; Ghadiri M; Ramezani M; Askari VR
Phytother Res; 2020 Apr; 34(4):685-720. PubMed ID: 31908068
[TBL] [Abstract][Full Text] [Related]
60. Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma.
Zhong C; Qiu S; Li J; Shen J; Zu Y; Shi J; Sui G
Phytomedicine; 2019 Jun; 59():152921. PubMed ID: 31055231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]